Brito MD, Silva GFG, Tilieri EM, Araujo BG, Calio Ml, ROSENSTOCK TR (2019) Metabolic alteration and Amyotrophic Lateral Sclerosis outcome: a systematic review. Front Neurol. 10:1205. doi: 10.3389/fneur.2019.01205.

Silva, LFS, Brito MD, Yuzawa JMC, ROSENSTOCK TR (2019) Hallmarks of mitochondrial dysfunction associated to hypoxia in spontaneously hypertensive rats astrocytes. Sci Rep. 9(1):18049. doi: 10.1038/s41598-019-53605-4.

Brito MD, Silva LFS, Siena A, Chipara M, Sarkar S, ROSENSTOCK TR (2019) Oxygen consumption: an important indicator of metabolic state, cellular function and cell fate along neural deregulation. Methods in Toxicity Assessment, Methods in Molecular Biology.

Prashanta Kumar Panda, Alexandra Fahrner, Somya Vats, Elena Seranova, Vartika Sharma, Miruna Chipara, Priyal Desai, Jorge Torresi, TATIANA ROSENSTOCK, Dhiraj Kumar, Sovan Sarkar (2019) Chemical screening approaches enabling drug discovery of autophagy modulators for biomedical applications in human diseases. Front Cell Dev Biol.7:38. doi: 10.3389/fcell.2019.00038.

Seranova E, Ward C, Chipara M, ROSENSTOCK T, Sarkar S. (2019) In vitro screening platforms for autophagy modulators in mammalian cells. Methods Mol Biol. 1880:389-428. doi: 10.1007/978-1-4939-8873-0_26.

Luana Naia, Catarina Carmo, Susanna Campesan, Carla Lopes, Jorge Valero, TATIANA R. ROSENSTOCK, Flaviano Giorgini, A Cristina Rego (2018) SIRT3, a modifier of mitochondrial function in Huntington's disease . Free Radical Biology and Medicine; 120; S17.



Seranova  E, Connolly K, Zatyka M, ROSENSTOCK T, Barrett T, Tuxworth R, Sarkar S. (2017) Dysregulation of autophagy as a common mechanism in lysosomal storage diseases. Essays in Biochemistry. 12;61(6):733-749.

Naia L, Cunha-Oliveira T, Rodrigues J, ROSENSTOCK TR, Oliveira A, Ribeiro M, Carmo C, Oliveira-Sousa SI, Duarte AI, Hayden MR, Rego AC (2017) Histone deacetylase inhibitors protect against pyruvate dehydrogenase dysfunction in Huntington's Disease. J Neurosci. 37(10):2776-2794.

Yamagata AS, Mansur RB, Rizzo LB,  ROSENSTOCK T, Mcintyre RS, Brietzke E  (2017) Selfish brain and selfish immune system interplay: a theoretical framework for metabolic comorbidities of mood disorders. Neurosci Biobehav Rev. 72:43-49


Luana Naia, TATIANA R. ROSENSTOCK, Ana M. Oliveira, Sofia I. Oliveira-Sousa, Gladys L. Caldeira, Catarina Carmo, Mário N. Laço, Michael R. Hayden, Catarina R. Oliveira, A. Cristina Rego (2016) Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington's disease models. Molecular Neurobiol. MOLN-D-16-00388.

Naia, L., Ribeiro, M., Rodrigues, J., Duarte, A.I., Lopes, C., ROSENSTOCK, T.R., Hayden, M.R., Rego, A.C. (2016) Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin. Neuropeptides. pii: S0143-4179(16)00017-2.

Xavier, A.M., Anunciato, A.K., ROSENSTOCK, T.R., Glezer, I. (2016) Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses – Frontiers in Endocrinology, 19;7:31

Xavier, A.M., Ludwig, R.G., Nagai, M.H., Almeida, T.J., Watanabe, H.M., Hirata, M.Y., ROSENSTOCK, T.R., Papes, F., Malnic, B., Glezer, I. (2016) CD36 is expressed in a defined subpopulation of neurons in the olfactory epithelium. Scientific reports 5;6:25507.

Naia, L., Ferreira, I.L., Cunha-Oliveira, T., Duarte, A.I., Ribeiro, M., ROSENSTOCK, T.R., Laço, M.N., Ribeiro, M.J., Oliveira, C.R., Saudou, F., Humbert, S., Rego, A.C. (2015) Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington's Disease Human Lymphoblasts. Mol Neurobiol. 51(1):331-48. 


Ribeiro, M., ROSENSTOCK, T.R., Oliveira, C.R., Rego, A.C. (2014) Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells. Free RadicBiol Med. 74C:129-144

ROSENSTOCK, T.R. (2014) Lysine (K)-deacetylase inhibitors: the real next step to neuropsychiatric and neurodegenerative disorders? Biohelikon: Cell Biology, 2:a8. ISSN: 2348–3741.

Brett, A.C., ROSENSTOCK, T.R., Rego, A.C (2014) Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease. Curr Drug Targets. PMID: 24266585

Ribeiro, M., ROSENSTOCK, T.R., Cunha-Oliveira, T., Ferreira, I.L., Oliveira, C.R., Rego, A.C. (2012) Glutathione redox cycle dysregulation in Huntington’s disease knock-in striatal cells. Free Radic Biol Med. 15;53(10):1857-67.

ROSENSTOCK, T.R., Brett, A.C., Rego, A.C (2012) Neuronal pathways affected in Huntington’s Disease. Review book titled “Multidisciplinary viewpoint on neurodegenerative diseases” (Editors: Dr. Marta Di Carlo, Dr. P.L. San Biagio and Dr. D. Bulone) - Research Signpost/Transworld Research Network - ISBN 978-81-7895-557-5.

ROSENSTOCK, T.R., Rego, A.C (2012) Modified mitochondrial dynamics, turnover and function in neurodegeneration: a focus on Huntington’s Disease. Review book titled“Cellular Bioenergetics in Health and Diseases: New Perspectives in Mitochondrial Biology” (Editor:Phing-How Lou, PhD; Co-Editor: Natalia Gustavsson, MD, PhD) - Transworld Research Network - ISBN 978-81-308-0487-3.


ROSENSTOCK, T.R., de Brito, O.M., Lombardi, V., Louros, S., Ribeiro, M., Almeida, S., Ferreira, I.L., Oliveira, C.R., Rego, A.C. (2011) FK506 ameliorates cell death features in Huntington's disease striatal cell models. Neurochem Int. 59(5):600-9. 

ROSENSTOCK, T.R., Duarte, A.I., Rego, A.C. (2010) Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench.Curr Drug Targets. 11(10):1218-36. Review. 

ROSENSTOCK, T.R.,Bertoncini, C.R.A., Teles, A.V., Hirata H, Fernandes, M. J., Smaili, S.S. (2010). Glutamate-induced alterations in Ca2+ signaling are modulated by mitochondrial Ca2+ handling capacity in brain slices of R6/1 transgenic mice. Eur J Neurosci. 32(1):60-70


Smaili, S., Hirata, H., Ureshino, R., Monteforte, P.T., Morales, A.P., Muler, M.L., Terashima, J., Oseki, K., ROSENSTOCK, T.R., Lopes, G.S., Bincoletto, C. (2009) Calcium and cell death signaling in neurodegeneration and aging. An Acad Bras Cienc. 81(3): 467-475.

ROSENSTOCK, T.R., Abílio, V.C., Frussa-Filho, R., Kiyomoto, B.H., Smaili, S.S. (2009) Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid. Pharmacol Biochem Behav. 91: 327–332.

Smaili, S.S., ROSENSTOCK T.R., Hsu, Y.T. (2008) Evaluation of some cell death features by real time real space microscopy. Methods Enzymol. 442: 27-50.


Teles, A.V., ROSENSTOCK, T.R., Okuno, C.S., Lopes, G.S., Bertoncini, C.R., Smaili, S,S. (2008) Increase in bax expression and apoptosis are associated in Huntington´s disease progression. Neurosci Lett. 438(1): 59-63.

ROSENSTOCK, T.R., Carvalho, A.C.P., Jurkiewicz, A., Frussa-Filho, R., Smaili, S.S. (2004) Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J. Neurochem. 88: 1220-1228.


Carvalho, A.C.P., Sharpe, J., ROSENSTOCK, T.R., Teles, A.F., Kowaltowski, A.J., Youle, R.J., Smaili, S.S. (2004) Bax affects intracellular Ca(2+) stores and induces Ca(2+) wave propagation. Cell Death Differ. 11(12):1265-1276. Erratum in: Cell Death Differ. 2005 Jan;12(1):105.

Smaili, S.S., Hsu, Y.-T., Carvalho, A.C.P., ROSENSTOCK, T.R., Sharpe, J.C., Youle, R.J. (2003) Mitochondria, calcium and pro-apoptotic proteins as mediators in cell death signaling. Braz. J. Med. Biol. Res. 36: 183-190.

Chapter’s revision of the book: BIOQUÍMICA CLÍNICA 3ED; MARSHALL, WILLIAM/LAPSLEY,MARTA (Chapters 4, 5, 6, 13, 28, 33, 35, 40, 41) – ISBN: 978-85-352-8276-4


Chapter’s translation of the book: BIOQUÍMICA CLÍNICA 3ED; MARSHALL, WILLIAM/LAPSLEY,MARTA (Chapter 16) – ISBN: 978-85-352-8276-4











Book Chapter - Translation